From the ASX ann 15-2-16
PTX Chairman, Steven Engle said, “After a broad search for the best possible leader to take PTX forward, it became very clear that Steven was the ideal candidate for the role. As a non-executive director of the Company since its founding, he understands the business strategy well, and moreover, has a deep appreciation and knowledge of our science and its application in the clinical setting. We are delighted to have him as Managing Director.”
Steve is an original director and no doubt the financial engineer behind the reverse merger into Virax. He has been roadshowing PTX in Aus and the US for some time now. If you couldn't get a chace to see/hear/meet him at the AGM, here he is presenting PTX in January http://noble.mediasite.com/mediasite/Play/077aa262f93f4152891d344b839c310f1d
- Forums
- ASX - By Stock
- Ann: PTX Featured on Bloomberg's - The Redchip Money Report
From the ASX ann 15-2-16 PTX Chairman, Steven Engle said, “After...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $32.21M |
Open | High | Low | Value | Volume |
4.0¢ | 4.1¢ | 4.0¢ | $22.35K | 558.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 221774 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 860576 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 249700 | 0.043 |
3 | 145000 | 0.042 |
6 | 477461 | 0.041 |
7 | 247800 | 0.040 |
3 | 130000 | 0.039 |
Price($) | Vol. | No. |
---|---|---|
0.046 | 99540 | 2 |
0.047 | 18686 | 2 |
0.048 | 200000 | 1 |
0.049 | 194091 | 3 |
0.050 | 427445 | 9 |
Last trade - 14.51pm 19/11/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |